1 / 106

MODULE 4 PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

MODULE 4 PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK. PREGNANCY AT RISK PREGESTATIONAL GESTATIONAL CHILDBIRTH AT RISK PRE—LABOR COMPLICATIONS LABOR—RELATED COMPLICATIONS POSTPARTUM AT RISK. MODULE 4 PART 1A PREGESTATIONAL RISKS SUBSTANCE ABUSE. SUBSTANCE ABUSE DURING PREGNANCY.

sadamson
Download Presentation

MODULE 4 PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. MODULE 4 PREGNANCY, CHILDBIRTH, AND POSTPARTUM AT RISK

  2. PREGNANCY AT RISK • PREGESTATIONAL • GESTATIONAL CHILDBIRTH AT RISK • PRE—LABOR COMPLICATIONS • LABOR—RELATED COMPLICATIONS • POSTPARTUM AT RISK

  3. MODULE 4 PART 1APREGESTATIONAL RISKSSUBSTANCE ABUSE

  4. SUBSTANCE ABUSE DURING PREGNANCY • ALCOHOL • CNS DEPRESSANT • INCIDENCE OF ABUSE HIGHEST IN MOTHERS 20-40 YEARS OF AGE • PREGNANT WOMEN SHOULD AVOID ALCOHOL COMPLETELY DURING PREGNANCY—WHY? • ADVERSE MATERNAL EFFECTS • ADVERSE FETUS/NEONATAL EFFECTS

  5. Fetal Alcohol Syndrome Retrieved from: http://www.aafp.org/afp/2005/0715/p279.html

  6. SUBSTANCE ABUSE DURING PREGNANCY • COCAINE AND CRACK • PREVENTS REUPTAKE OF DOPAMINE, NOREPINEPHRINE—LEADS TO VASOCONSTRICITION, TACHYCARDIA, HYPERTENSION • ADVERSE MATERNAL EFFECTS • ADVERSE FETAL/NEONATAL EFFECTS

  7. SUBSTANCE ABUSE DURING PREGNANCY • MARIJUANA • NO STRONG RESEARCH INDICATING TERATOGENIC EFFECTS • SOCIAL FACTORS • HEROIN/METHADONE • ADVERSE MATERNAL EFFECTS • ADVERSE FETAL/NEONATAL EFFECTS

  8. SUBSTANCE ABUSE DURING PREGNANCY • BARBITURATES • STIMULANTS • CAFFEINE • NICOTINE • PSYCHOTROPICS • METH

  9. MODULE 4 PART 1BPREGESTATIONAL RISKS: DIABETES

  10. DIABETES MELLITUS IN PREGNANCY • PATHOPHYSIOLOGY • INSULIN PRODUCTION DECREASE BY PANCREAS • WITHOUT ADEQUATE INSULIN, GLUCOSE DOES NOT ENTER CELLS, WHICH BECOME ENERGY DEPLETED • BLOOD GLUCOSE LEVELS INCREASE • CELLS BREAK DOWN PROTEIN AND FAT STORES FOR ENERGY

  11. DIABETES MELLITUS IN PREGNANCY • EARLY PREGNANCY • ESTROGEN, PROGESTERONE, OTHER HORMONES RISE TO STIMULATE INCREASED INSULIN PRODUCTION AND INCREASED TISSUE RESPONSE TO INSULIN • STORAGE OF GLYCOGEN IN LIVER PRODUCES ANABOLIC STATE DURING IST HALF OF PREGNANCY

  12. DIABETES MELLITUS IN PREGNANCY • 2ND HALF OF PREGNANCY PRESENTS WITH INCREASED RESISTANCETO INSULIN AND DECREASED GLUSOSE TOLERANCE DUE TO: • SECRETION OF Hpl (INSULIN ANTAGONIST) PROLACTIN, INCREASED CORTISOL AND GLYCOGEN LEVELS • RESULTS IN CATABOLIC STATE • DIABETOGENIC EFFECT

  13. DIABETES IN PREGNANCY • CLASSIFICATIONS • ETIOLOGIC • TYPE I • TYPE II • TYPE III • TYPE IV • BASED ON CAUSE • WHITE’S • CLASS A-T • DESCRIBES EXTENT OF DISEASE

  14. GESTATIONAL DIABETES • GESTATIONAL DIABETES • WHY DOES THIS OCCUR? -- WHEN DOES THIS OCCUR? • WHAT IS THE INCIDENCE OF THIS OCCURING DURING PRGNANCY? • HOW IS IT DIAGNOSED?

  15. COMPARISON OF DIABETES MELLITUS AND GESTATIONAL DIABETES

  16. DIABETES MELLITUS IN PREGNANCY • INTRAPARTAL MANAGEMENT • WHEN TO DELIVER • LABOR MANAGEMENT, INSULIN REQUIREMENTS • POSTPARTAL MANAGEMENT • INSULIN REQUIREMENTS • BREAST FEEDING

  17. DIABETES IN PREGNANCY • CHALLENGES, INFLUENCES • MATERNAL RISKS • FETAL, NEWBORN RISKS

  18. DIABETES MELLITUS IN PREGNANCY • CLINICAL TREATMENT • GTT CRITERIA • LAB ASSESSMENT • ANTEPARTAL MANAGEMENT • DIET • GLUCOSE MONITORING • INSULIN REQUIREMENTS • FETAL EVALUATION

  19. MODULE 4 PART 1CPREGESTATIONAL RISKSINFECTIONS

  20. HIV IN PREGNANCY • RISKS TO MOTHER • RISKS TO FETUS/NEONATE • ANTEPARTUM, INTRAPARTUM, POSTPARTUM TREATMENT & CARE

  21. TORCH • TOXOPLAMOSIS • OTHER • GBS • RUBELLA • CYTOMEGALIVIRUS • HERPES

  22. TORCH • MATERNAL RISKS • FETAL RISKS • ANTEPARTUM, INTRAPARTUM, POSTPARTUM TREATMENT AND CARE

  23. GROUP B STREPTOCOCCUS • INCIDENCE • TESTING • TREATMENT • NURSING INTERVENTIONS

  24. GESTATIONAL PREGNANCY RISKS • BLEEDING DISORDERS • HYPERTENSIVE DISORDER • Rh ALLOIMMUNIZATION • ABO INCOMPATIBILITY • DOMESTIC VIOLENCE • SURGERY, TRAUMA

  25. MODULE 4 PART 2AGESTATIONAL ONSET COMPLICATIONS:BLEEDING DISORDERS

  26. BLEEDING DISORDERS • ECTOPIC PREGNANCY • TREATMENT, RISKS • GESTATIONAL TROPHOBLASTIC DISEASE • HYDATIFORM MOLE • CHORIOADENOMA DESTRUENS • CHORIOCARCINOMA • TREATMENT, RISKS

  27. GESTATIONAL RISKS • INCOMPETENT CERVIX • CERCLAGE • HYPEREMESIS GRAVIDARUM • FLUID & ELECTROLYTE ISSUES • DEHYDRATION • RISKS TO FETUS • NURSING CARE

  28. Cerclage Retrieved from: www.drlindagalloway.wordpress.com

  29. GESTATIONAL RISKS • PREMATURE RUPTURE OF MEMBRANES • PROM • PPROM • NST, BPP RISKS NURSING CARE

  30. Positive Fern Test Retrieved from: commons.wikimedia.org

  31. MODULE 4 PART 2B GESTATIONAL COMPLICATIONS AND RISKS:PREGNANCY REDUCED HYPERTENSION

  32. PREGNANCY INDUCED HYPERTENSION--PIH • PREECLAMPSIA/ECLAMPSIA • CHRONIC HYPERTENSION • CHRONIC HYPERTENSION WITH SUPERIMPOSED PREECLAMPSIA OR ECLAMPSIA • TRANSIENT HYPERTENSION

  33. PREECLAMPSIA • DISEASE OF THEORIES • MOST COMMON HYPERTENSIVE DISORDER IN PREGNANCY • PATHOPHYSIOLOGY • CAUSE UNKNOWN • 5-7% OF ALL PREGNANCIES • GENERALIZED VASOSPASM, DECREASE IN CIRCULATING BLOOD VOLUME

  34. Preeclampsia

  35. PREECLAMPSIA • PRENATAL FACTORS INCREASING RISK OF PIH • PRIMIGRAVIDA • ESSENTIAL HYPERTENSION • AGE EXTREMES (UNDER 17 OR OVER 35 YEARS OLD) • UNDERWEIGHT OR OVERWEIGHT • FAMILY HISTORY OF HYPERTENSION • DIAGNOSIS OF PIH IN PREVIOUS PREGNANCY • DIABETES MELLITUS

  36. PREECLAMPSIA • CHARACTERIZED BY: • DEVELOPMENT OF HYPERTENSION • 30MM HG INCREASE IN SYSTOLIC AND 15 MM HG DIASTOLIC OVER BASELINE ON AT LEAST 2 OCCASIONS 6 OR MORE HOURS APART • PROTEINURIA • EDEMA • MATERNAL RISKS • FETAL/NEONATAL RISKS

  37. PREECLAMPSIA • CLINICAL MANAGEMENT/CARE • ANTEPARTAL MANAGEMENT • MILD PREECLAMPSIA • SEVERE PREECLAMPSIA • INTRAPARTAL MANAGEMENT • POSTPARTAL MANAGEMENT • HELLP SYNDROME • ECLAMPSIA

  38. H E L L P Syndrome • H – hemolysis- distortion and rupture of RBCs • E – elevated • L – liver enzymes- fibrin deposits obstruct blood flow • L – low • P – platelet count

  39. MODULE 4 PART 2CGESTATIONAL RISKS & COMPLICATIONS: Rh ISOIMMUNIZATION

  40. Rh SENSITIZATION • ANTIGEN-ANTIBODY RESPONSE • IF AN Rh-NEGATIVE WOMAN IS EXPOSED TO Rh POSITIVE BLOOD, EITHER THROUGH TRANSFUSION OR A PRIOR PREGNANCY, SHE PRODUCES IMMUNOGLOBULIN (Ig)G ANTIBODY (ANTIRhD) • INDIRECT COOMBS TEST • DIRECT COOMBS TEST

More Related